Patent details

Basic Information

Publication number:

EP3062881

PCT Application Number:

US2014062378

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148570666

PCT Publication Number:

WO2015065897

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CANCER MODELS AND ASSOCIATED METHODS

French Title of Invention:

MODÈLES DE CANCER ET PROCÉDÉS ASSOCIÉS

German Title of Invention:

KREBSMODELLE UND ZUGEHÖRIGE VERFAHREN

SPC Number:

Dates

Filing date:

27/10/2014

Grant date:

02/10/2019

EP Publication Date:

07/09/2016

PCT Publication Date:

07/05/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/10/2019

EP B1 Publication Date:

02/10/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/10/2019

Expiration date:

27/10/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/09/2019

 

 

Name:

NGM Biopharmaceuticals, Inc.

Address:

333 Oyster Point Blvd., South San Francisco CA 94080, United States (US)

Inventor

Name:

LING, Lei

Address:

United States (US)

Priority

1

Priority Number:

201361896473 P

Priority Date:

28/10/2013

Priority Country:

United States (US)

2

Priority Number:

201361922586 P

Priority Date:

31/12/2013

Priority Country:

United States (US)

3

Priority Number:

201462067273 P

Priority Date:

22/10/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/18; A61P 3/10;

Publication

European Patent Bulletin

Issue number:

201940

Publication date:

02/10/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages